Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-21-012947
Filing Date
2021-06-25
Accepted
2021-06-25 16:31:55
Documents
7
Effectiveness Date
2021-06-25
Reference 429
333-253454

Document Format Files

Seq Description Document Type Size
1 S-8 auph-2021junesx8eipandespp.htm S-8 104429
2 EX-5.1 exhibit51opinionandconsent.htm EX-5.1 11323
3 EX-10.1 a2021-auriniaamendedandres.htm EX-10.1 118823
4 EX-10.2 auriniaespp04142021.htm EX-10.2 107626
5 EX-23.2 exhibit232consentofpwcjune.htm EX-23.2 1078
6 blgheader2a.jpg GRAPHIC 20360
7 pwcconsents8june252021.jpg GRAPHIC 74286
  Complete submission text file 0001628280-21-012947.txt   464167
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257424 | Film No.: 211048352
SIC: 2834 Pharmaceutical Preparations